ARM vs REGN · P/E 203, rev $4.01B vs P/E 14, rev $14.34B
Arm Holdings plc American Depositary Shares (ARM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Arm Holdings plc American Depositary Shares (ARM) is a semiconductors company listed on US. It is led by Rene Haas.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ARM revenue for 2025-03-31 was $4.01B. Net income was $792.0M. Revenue was up 23.9% from 2024-03-31 to 2025-03-31. ARM currently screens at market cap $163.79B and trailing P/E 203.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ARM currently screens at market cap $163.79B and trailing P/E 203.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ARM and REGN stock pages for the full models.
Not investment advice.